Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Closed |
as soon as is submitted to ZB.
At the right time: Moving precision therapy to newly diagnosed cancer.
Med. 5, 1463-1465 (2024)
Precision oncology aims to match the right drug(s) to the right patient. Equally important is ensuring that precision therapies are offered at the right time. Transformative, rather than incremental, outcome improvement may require treatment at diagnosis rather than in the advanced/metastatic setting after genomic evolution.
Altmetric
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Letter to the Editor
Keywords
Chronic Myeloid-leukemia
Language
english
Publication Year
2024
HGF-reported in Year
2024
ISSN (print) / ISBN
2666-6359
e-ISSN
2666-6340
Journal
Med (N Y)
Quellenangaben
Volume: 5,
Issue: 12,
Pages: 1463-1465
Publisher
Cell Press
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Reviewing status
Peer reviewed
Institute(s)
Institute of Metabolism and Cell Death (MCD)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506900-001
Grants
NCI
WOS ID
001388081000001
Scopus ID
85211318207
PubMed ID
39674173
Erfassungsdatum
2024-12-16